Galena Biopharma fka GALE

[JonathanTel]

http://www.sec.gov/Archives/edgar/data/1390478/999999999714009589/filename1.pdf

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
May 12, 2014

ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934

Galena Biopharma, Inc.

File No. 001-33958 - CF#30863
_____________________

Galena Biopharma, Inc. submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-K filed
on March 17, 2014.

Based on representations by Galena Biopharma, Inc. that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:

Exhibit 2.1 through March 17, 2019
Exhibit 10.36 through January 13, 2024
Exhibit 10.37 through December 20, 2016

For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:



Kevin M. O’Neill
Deputy Secretary